Showing results (751-760 of 1,020) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|October 14, 2026
microRNA expression in macrophages regulates antibody-dependent effector function and B cell lymphoma therapyJemma Longley, Lekh N Dahal, Russell B Foxall, et al.Cancer Research Communications|October 20, 2026
Comparative analysis of ovarian cancer tumor-infiltrating T cells with those in melanoma and before and after PD-1 blockadeIlaria Colombo, Ksenia Meteleva, Simone C Stone, et al.Cancer Research Communications|February 21, 2022
HSP70 inhibition blocks adaptive resistance and synergizes with MEK inhibition for the treatment of NRAS-mutant melanomaJoshua L D Parris, Thibaut Barnoud, Julia I-Ju Leu, et al.Cancer Research Communications|April 8, 2022
Phase I Study of High-Dose L-methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH wild-type High-Grade GliomaLucas A Salas, Thomas G Stewart, Bret C Mobley, et al.Cancer Research Communications|December 19, 2022
A miniaturized screening platform to identify novel regulators of extracellular matrix alignmentCaitlin E Jones, Joe T Sharick, Steven T Sizemore, et al.Cancer Research Communications|August 28, 2025
Response to anti-angiogenic therapy is associated with AIMP protein family expression in glioblastoma and lower-grade gliomasHumaira Noor, Yuanning Zheng, Haruka Itakura, et al.Cancer Research Communications|January 27, 2023
Three-dimensional Imaging Reveals Immune-driven Tumor-associated High Endothelial Venules as a Key Correlate of Tumor Rejection Following Depletion of Regulatory T CellsStefan Milutinovic, Jun Abe, Emma Jones, et al.Cancer Research Communications|September 9, 2022
GLS1 is a protective factor in patients with ovarian clear cell carcinoma and its expression does not correlate with ARID1A-mutated tumorsValentino Clemente, Asumi Hoshino, Mihir Shetty, et al.Cancer Research Communications|December 24, 2021
Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A InhibitionEric D Eisenmann, Qiang Fu, Elizabeth M Muhowski, et al.Cancer Research Communications|October 31, 2022
The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool For Ovarian Cancer Immunotherapy ResearchGalaxia M Rodriguez, Kristianne J C Galpin, David P Cook, et al.Pageof 102